Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Neuroscience Capacity Accelerator For Mental Health

International Brain Research Organization (IBRO)

Grant aim: This program aims to enhance neuroscience research related to mental health in Low- and Middle-Income Countries (LMICs), with a focus on building research capacity and accelerating the potential for impactful research programs.

Status: Open

Applications: 1 Mar 2025 - 30 Apr 2025

Grant type: Career Development

Open to: International

Maximum grant amount: USD 60,000

About this program

Commissioned by Wellcome, the International Brain Research Organization (IBRO) is delivering the Neuroscience Capacity Accelerator for Mental Health (NCAMH), which aims to accelerate the development of impactful neuroscience research in Low- and Middle-Income Countries (LMICs) by strengthening local capacities through targeted training and fostering collaborative research projects. Our goal is to leverage neuroscience to drive progress in both basic and translational research on anxiety, depression and psychosis*. This call seeks to fund projects that enhance our understanding of these conditions and/or identify new approaches for predicting, stratifying, and intervening as early as possible.

Each selected project will be supported with up to USD $60,000 in funding. Please note that salary and other overhead expenses are not eligible for funding under this grant.

*We define anxiety, depression, and psychosis in their broadest sense, encompassing all types of anxiety and depressive disorders (including obsessive compulsive disorder and post-traumatic stress disorder) and all forms of psychotic disorders (including schizophrenia, postpartum psychosis, and bipolar disorder).

Specialties

Mental Health

Psychology

Neurosciences

Eligibility Requirements

Collaboration Details:

This program is open to researchers and clinicians with existing collaborations or those seeking new opportunities to expand their research with a small group of partners (typically 2-3 collaborators in total).
Collaborations may be international or domestic.
Project collaborators must be from different institutions. Collaborators from the same institution, even if they belong to different departments, do not meet this requirement.
Applicants can be employed by higher education institutions, research institutes, non-academic healthcare organisations, or not-for-profit organizations.
Individuals who have previously received a NCAMH grant (or previously served as a project collaborator) are not eligible to apply.

Project Leaders:

Project leaders must be based in and affiliated with an institution in a LMIC and have the experience and support structures necessary to drive and lead a collaborative research project.
Project leaders must hold independent investigator status at the LMIC institution, meaning they are eligible to serve as a Principal Investigator (PI) on independent research grants. They do not need to currently hold a grant, but their institutional role must allow them to apply for and manage external funding as the lead researcher. We understand that job titles may vary according to regional context.

Project Collaborators:

Project collaborators are not required to be based in or affiliated with a LMIC.
Project collaborators must hold independent investigator status if joining the project in the capacity of a researcher.
Project collaborators must bring complementary skills and resources essential to the delivery of the project.

Project proposals should:

Start from September 2025 and be for a duration of 9 months.
Focus on advancing knowledge in neuroscience with relevance to furthering our understanding of the development and/or resolution of anxiety, depression and psychosis as broadly defined categorizations, or exploring new opportunities for early interventions in these conditions.
Demonstrate the potential for long-term scientific collaboration, with a clear plan for developing future research proposals.
Address ethical considerations in both study design and uptake (if applicable).

Teams conducting research projects involving human participants and collecting data on anxiety and/or depression must use at least one of the following recommended measures, relevant to their research question:

Patient Health Questionnaire PHQ-9 (adults – depression)
General Anxiety Disorder questionnaire GAD-7 (adults – anxiety)
Revised Child Anxiety and Depression Scale RCADS-25 (children and adolescents – depression and anxiety)
World Health Organisation Disability Assessment Schedule WHODAS-12 (adults – impact on functioning)

Sponsor Details

Sponsor Institute/Organizations: International Brain Research Organization (IBRO)

Sponsor Type:

Address: Rue d’Egmont 11, 1000, Brussels, Belgium | +32 2 426 56 96

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity